Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety, Efficacy, and Immunogenicity of a Multivalent Adjuvanted S. aureus Vaccine in Adults with Recent Skin And Soft Tissue Infections: An Observer-blind, Randomized, Placebo-controlled, Multinational Phase 1/2 Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Mortality by income in the elderly population in Italy: new evidence from an innovative microdata integration.

Journal of epidemiology and community health·2026
Same author

Age- and sex-patterns of suicide trends in Europe: 1990-2022 comparative analysis of official WHO mortality data - CORRIGENDUM.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same author

Age- and sex-patterns of suicide trends in Europe: 1990-2022 comparative analysis of official WHO mortality data.

European psychiatry : the journal of the Association of European Psychiatrists·2025
Same author

Developing a Classification of Spinal Medical Devices: Has the Time Come? Review of the Literature and a Proposal for Spine Registries.

Bioengineering (Basel, Switzerland)·2025
Same author

Diabetes-related mortality in the immigrant compared to the Italian population, before and during the pandemic.

Journal of endocrinological investigation·2025

Related Experiment Video

Updated: Jun 26, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Multiple tumours in survival estimates.

Stefano Rosso1, Roberta De Angelis, Laura Ciccolallo

  • 1CPO-Piedmont Cancer Registry, via San Francesco da Paola 31, 10123 Torino, Italy. Stefano.rosso@cpo.it

European Journal of Cancer (Oxford, England : 1990)
|January 6, 2009
PubMed
Summary
This summary is machine-generated.

Including multiple primary cancers in survival analyses reduces bias in international cancer comparisons. This approach lowers survival estimates, particularly for older registries and specific cancer sites, ensuring more accurate data.

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Related Experiment Videos

Last Updated: Jun 26, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Area of Science:

  • Oncology
  • Cancer Epidemiology
  • Biostatistics

Background:

  • International cancer survival comparisons commonly exclude multiple primary tumors.
  • Excluding multiple cancers can introduce bias due to varying registry running times and detection rates.
  • This practice may lead to inaccurate comparisons of cancer survival across different European populations.

Purpose of the Study:

  • To evaluate the impact of including multiple primary tumors on age-standardized relative survival estimates.
  • To assess how including multiple cancers affects survival data in international cancer registry comparisons.
  • To determine if including multiple primary tumors improves the accuracy and reduces bias in survival estimates.

Main Methods:

  • Analysis of 2,919,023 malignant cancers from 69 European cancer registries (EUROCARE-4 study).
  • Identification and inclusion of 183,683 multiple primary tumors (6.3% of total cancers).
  • Comparison of age-standardized relative survival estimates with and without the inclusion of multiple primary tumors.

Main Results:

  • Including multiple primary tumors generally lowered five-year relative survival estimates.
  • Average reduction in survival was -0.4% for women and -0.7% for men across all cancers.
  • The greatest survival reductions were observed for larynx (-1.9%), oropharynx (-1.5%), and penis (-1.3%) cancers.

Conclusions:

  • Including multiple primary tumors in survival estimates is advisable for international comparisons.
  • This inclusion reduces bias stemming from different observation periods, age structures, and registration quality.
  • The overall effect is a variable reduction in survival estimates, dependent on the proportion of multiple primaries and cancer site.